Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

6.28
Delayed Data
As of Feb 05
 -0.35 / -5.28%
Today’s Change
5.77
Today|||52-Week Range
32.85
-31.96%
Year-to-Date

Today’s Trading

Previous close6.63
Today’s open6.56
Day’s range6.24 - 6.75
Volume1,530,822
Average volume (3 months)3,440,656
Market cap$605.0M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-81.16%
Earnings growth (this year)-41.60%
Earnings growth (next 5 years)+22.50%
Revenue growth (last year)-56.61%
P/E ratioNM
Price/Sales1,224.45
Price/Book1.93

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc-2.22-6.72%
ANIKAnika Therapeutics I...-0.48-1.26%
ATRCAtriCure Inc-0.83-4.67%
ATRIAtrion Corp-10.94-2.89%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$1.8M
Annual profit (last year)-$100.0M
Net profit margin-5,564.40%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts

Partner Offers